Robert Farinotti

5 Rue Jean Baptiste Clémént, Cedex
Chatenay-sur-seine, 92296, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 22 publications

Correlation between clinical response to sorafenib in hepatocellular carcinoma treatment and polymorphisms of P-glycoprotein (ABCB1) and of breast cancer resistance protein (ABCG2): monocentric study.

Correlation between clinical response to sorafenib in hepatocellular carcinoma treatment and polymorphisms of P-glycoprotein (ABCB1) and of breast cancer resistance protein (ABCG2): monocentric study.

Journal: Cancer chemotherapy and pharmacology

Published: November 04, 2016

Age-Dependent Regulation of the Blood-Brain Barrier Influx/Efflux Equilibrium of Amyloid-β Peptide in a Mouse Model of Alzheimer's Disease (3xTg-AD).

Age-Dependent Regulation of the Blood-Brain Barrier Influx/Efflux Equilibrium of Amyloid-β Peptide in a Mouse Model of Alzheimer's Disease (3xTg-AD).

Journal: Journal of Alzheimer's disease : JAD

Published: October 21, 2015

Cetuximab directly inhibits P-glycoprotein function in vitro independently of EGFR binding.

Cetuximab directly inhibits P-glycoprotein function in vitro independently of EGFR binding.

Journal: European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences

Published: November 24, 2014

Propofol, midazolam, vancomycin and cyclosporine therapeutic drug monitoring in extracorporeal membrane oxygenation circuits primed with whole human blood.

Propofol, midazolam, vancomycin and cyclosporine therapeutic drug monitoring in extracorporeal membrane oxygenation circuits primed with whole human blood.

Journal: Critical care (London, England)

Published: October 17, 2014

Preclinical impact of bevacizumab on brain and tumor distribution of irinotecan and temozolomide.

Preclinical impact of bevacizumab on brain and tumor distribution of irinotecan and temozolomide.

Journal: Journal of neuro-oncology

Published: May 30, 2014

Irinotecan and temozolomide brain distribution: a focus on ABCB1.

Irinotecan and temozolomide brain distribution: a focus on ABCB1.

Journal: Cancer chemotherapy and pharmacology

Published: April 01, 2014

Disturbed intestinal nitrogen homeostasis in a mouse model of high-fat diet-induced obesity and glucose intolerance.

Disturbed intestinal nitrogen homeostasis in a mouse model of high-fat diet-induced obesity and glucose intolerance.

Journal: American journal of physiology. Endocrinology and metabolism

Published: January 16, 2014

Cetuximab increases concentrations of irinotecan and of its active metabolite SN-38 in plasma and tumour of human colorectal carcinoma-bearing mice.

Cetuximab increases concentrations of irinotecan and of its active metabolite SN-38 in plasma and tumour of human colorectal carcinoma-bearing mice.

Journal: Fundamental & clinical pharmacology

Published: September 16, 2013

Altered cerebral vascular volumes and solute transport at the blood-brain barriers of two transgenic mouse models of Alzheimer's disease.

Altered cerebral vascular volumes and solute transport at the blood-brain barriers of two transgenic mouse models of Alzheimer's disease.

Journal: Neuropharmacology

Published: May 27, 2013

Oatp1a4 and an L-thyroxine-sensitive transporter mediate the mouse blood-brain barrier transport of amyloid-β peptide.

Oatp1a4 and an L-thyroxine-sensitive transporter mediate the mouse blood-brain barrier transport of amyloid-β peptide.

Journal: Journal of Alzheimer's disease : JAD

Published: May 03, 2013

Development of a new UPLC-MSMS method for the determination of temozolomide in mice: application to plasma pharmacokinetics and brain distribution study.

Development of a new UPLC-MSMS method for the determination of temozolomide in mice: application to plasma pharmacokinetics and brain distribution study.

Journal: Biomedical chromatography : BMC

Published: December 19, 2012

Influence of the multidrug transporter P-glycoprotein on the intracellular pharmacokinetics of vandetanib.

Influence of the multidrug transporter P-glycoprotein on the intracellular pharmacokinetics of vandetanib.

Journal: European journal of drug metabolism and pharmacokinetics

Published: December 05, 2012

Showing 1-12 of 22

Last Updated: 09/26/2026